Przemysław Borowy

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Michael G. Ison, Alberto Papi, Eugene Athan et al. · Clinical Infectious Diseases · 2024 · 162 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The incidence and risk of hip fracture in Poland

E. J. Czerwiński, J. A. Kanis, Bartosz Trybulec et al. · Osteoporosis International · 2008 · 57 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

Robert G. Feldman, Raffaele Antonelli Incalzi, Katie Steenackers et al. · Clinical Infectious Diseases · 2023 · 52 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17